Literature DB >> 16644705

Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion.

Aneliya I Parvanova1, Roberto Trevisan, Ilian P Iliev, Borislav D Dimitrov, Monica Vedovato, Antonio Tiengo, Giuseppe Remuzzi, Piero Ruggenenti.   

Abstract

Microalbuminuria is a risk factor for renal and cardiovascular disease. A role for insulin resistance in the pathogenesis of microalbuminuria has been suggested but is still unproven. In this case-control, cross-sectional study, we compared glucose disposal rate (GDR), measured by hyperinsulinemic-euglycemic clamp, in 50 pairs of matched type 2 diabetic patients with micro- or normoalbuminuria (main study) and in 29 matched pairs of diabetic patients with macro- or microalbuminuria (substudy). In the main study, GDR was approximately 25% lower in micro- than in normoalbuminuric patients (5.20 +/- 1.91 vs. 6.86 +/- 2.88 mg . kg(-1) . min(-1), P < 0.05) and was independently associated with microalbuminuria (P = 0.002), with each 1 mg . kg(-1) . min(-1) decrease predicting approximately 40% increased prevalence (odds ratio 1.37 [95% CI 1.14-1.70]). Microalbuminuria was threefold more frequent in patients with GDR < or =7.50 +/- 2.56 mg . kg(-1) . min(-1) than in those with higher GDR (60% vs. 20%, P < 0.005). In the substudy, GDR in macro- and microalbuminuric patients was comparable (5.52 +/- 2.56 vs. 5.16 +/- 1.61 mg . kg(-1) . min(-1)) and independent of macroalbuminuria. GDR was significantly correlated with urinary albumin excretion rate in the main study (P = 0.004) but not in the substudy (P = 0.60). In type 2 diabetes, more severe insulin resistance is independently associated with microalbuminuria. Longitudinal studies are needed to clarify the role of insulin resistance in the pathogenesis of microalbuminuria and related complications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644705     DOI: 10.2337/db05-1484

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  58 in total

Review 1.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

Review 2.  Metabolic acidosis-induced insulin resistance and cardiovascular risk.

Authors:  Gema Souto; Cristóbal Donapetry; Jesús Calviño; Maria M Adeva
Journal:  Metab Syndr Relat Disord       Date:  2011-02-25       Impact factor: 1.894

3.  Insulin resistance is associated with the development of albuminuria in Korean subjects without diabetes.

Authors:  Cheol Min Jang; Young Youl Hyun; Kyu Beck Lee; Hyang Kim
Journal:  Endocrine       Date:  2014-03-28       Impact factor: 3.633

Review 4.  Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.

Authors:  Frank C Brosius; Richard J Coward
Journal:  Adv Chronic Kidney Dis       Date:  2014-05       Impact factor: 3.620

Review 5.  Podocytopathy in diabetes: a metabolic and endocrine disorder.

Authors:  Ana Diez-Sampedro; Oliver Lenz; Alessia Fornoni
Journal:  Am J Kidney Dis       Date:  2011-06-29       Impact factor: 8.860

6.  Predictors of urinary albumin excretion in women with polycystic ovary syndrome.

Authors:  Antoni J Duleba; Ibrahim M Ahmed
Journal:  Fertil Steril       Date:  2009-02-12       Impact factor: 7.329

7.  Association between higher serum fetuin-A concentrations and abnormal albuminuria in middle-aged and elderly chinese with normal glucose tolerance.

Authors:  Mian Li; Min Xu; Yufang Bi; Aiyun Song; Yu Liu; Xiaoying Li; Guang Ning
Journal:  Diabetes Care       Date:  2010-08-16       Impact factor: 19.112

8.  Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy.

Authors:  Ko Hanai; Tetsuya Babazono; Izumi Nyumura; Kiwako Toya; Mari Ohta; Ryotaro Bouchi; Kumi Suzuki; Aiko Inoue; Yasuhiko Iwamoto
Journal:  Clin Exp Nephrol       Date:  2009-12-01       Impact factor: 2.801

9.  Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Authors:  E Ritz; G C Viberti; L M Ruilope; A J Rabelink; J L Izzo; S Katayama; S Ito; A Mimran; J Menne; L C Rump; A Januszewicz; H Haller
Journal:  Diabetologia       Date:  2009-10-30       Impact factor: 10.122

10.  Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.

Authors:  Salvatore De Cosmo; Nicola Motterlini; Sabrina Prudente; Fabio Pellegrini; Roberto Trevisan; Antonio Bossi; Giuseppe Remuzzi; Vincenzo Trischitta; Piero Ruggenenti
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.